Summer Soleil Hammond, | |
515 S 700 E Ste 2a, Salt Lake City, UT 84102-2855 | |
(800) 434-8923 | |
Not Available |
Full Name | Summer Soleil Hammond |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | 515 S 700 E Ste 2a, Salt Lake City, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538760228 | NPI | - | NPPES |
2009802557 | Other | NATIONAL GENERAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 18004622123 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Summer Soleil Hammond, 926 E Ibis Way, Draper, UT 84020-8749 Ph: (801) 513-0417 | Summer Soleil Hammond, 515 S 700 E Ste 2a, Salt Lake City, UT 84102-2855 Ph: (800) 434-8923 |
News Archive
In the wake of a landmark decision by Federal District Judge Nicholas Garaufis, who in early September ruled that New York State is violating the Americans with Disabilities Act by segregating individuals with mental illness from the general population and fostering "learned helplessness," detrimental to rehabilitation and recovery, Community Access is inviting neighbors, local businesses and friends to tour its supportive housing sites in New York City this October
The team at Texas Children's Fetal Center, a national leader for treating fetal anomalies, has successfully completed two in-utero fetal cardiac interventions to treat hypoplastic left heart syndrome (HLHS), a congenital heart defect that is one of the most complex heart defects to treat.
New research shows that children with febrile status epilepticus (FSE) who receive earlier treatment with antiepileptic drugs (AEDs) experience a reduction in the duration of the seizure.
RedHill Biopharma Ltd., an emerging Israeli biopharmaceutical company focusing primarily on development of late clinical-stage (Phase II/III), patent protected, new formulations and combinations of existing drugs, announces positive results in a pivotal bioequivalence clinical trial with RHB-103, an oral thin-film formulation of Rizatriptan for the treatment of acute migraine.
› Verified 9 days ago
Dr. Harriet W Hopf, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, U Of U Department Of Anesthesiology, Salt Lake City, UT 84158 Phone: 801-581-6393 Fax: 801-581-4367 | |
Karl A. Nielson, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 250 E 200 S Rm 1202, Salt Lake City, UT 84111 Phone: 801-581-3841 | |
Mrs. Alice Dowling, M.D., M.P.H. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3837 E Sunnydale Ln, Salt Lake City, UT 84108 Phone: 801-583-0544 | |
Tran Nam Le, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 250 E 200 S Rm 1202, Salt Lake City, UT 84111 Phone: 801-581-3841 | |
Dr. James R. Saullo, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 250 E 200 S Rm 1202, Salt Lake City, UT 84111 Phone: 801-581-3841 | |
Dr. Mark Vernon Anderson, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2390 S Redwood Rd, Salt Lake City, UT 84119 Phone: 801-975-1600 Fax: 801-975-1666 | |
Dr. Matthew Adams Hughes, M.D., M.P.H Preventive Medicine Medicare: Medicare Enrolled Practice Location: 391 Chipeta Way Ste C, Salt Lake City, UT 84108 Phone: 801-581-8719 Fax: 801-581-7224 |